TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma-Reference-Cited by-同舟云学术

TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

Published:2008-08-01 Issue:2 Volume:16 Page:149-160
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Enderlin M,Kleinmann E V,Struyf S,Buracchi C,Vecchi A,Kinscherf R,Kiessling F,Paschek S,Sozzani S,Rommelaere J,Cornelis J J,Van Damme J,Dinsart C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt200862.pdf

Reference68 articles.

1. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999; 91: 1382–1390.

2. Burton EC, Prados MD . Malignant gliomas. Curr Treat Options Oncol 2000; 1: 459–468.

3. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL et al. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci USA 1996; 93: 2909–2914.

4. Leach DR, Krummel MF, Allison JP . Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271: 1734–1736.

5. Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MA, Black KL et al. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther 2002; 9: 925–934.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments;Frontiers in Immunology;2024-06-26

2. Glioblastoma stem cell metabolism and immunity;Cancer and Metastasis Reviews;2024-03-26

3. Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity;Nano Today;2024-02

4. Immunotherapy in glioblastoma treatment: Current state and future prospects;World Journal of Clinical Oncology;2023-04-24

5. Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer;Biotechnology Letters;2023-01-18